Ray Sumita 4
4 · Biomea Fusion, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Biomea (BMEA) Director Ray Sumita Receives Option Award
What Happened Ray Sumita, a director of Biomea Fusion, was awarded a derivative equity grant on 2026-06-10 covering 196,299 shares. The reported acquisition price is $0.00 (no cash outlay reported). This filing reports an award/grant (transaction code A) rather than a market purchase or sale.
Key Details
- Transaction date: 2026-06-10; Form 4 filed 2026-06-12 (timely filing).
- Instrument: Derivative — stock option award covering 196,299 shares, reported at $0.00.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Footnote: The shares underlying the option vest in full upon the earlier of (i) one year after grant or (ii) immediately prior to the next annual meeting, subject to continued service by the reporting person.
- No sale or immediate cashless exercise reported.
Context This was an equity compensation grant to a board member — common for directors as part of compensation. The award vests based on continued service within about a year, so the shares are not yet freely tradable. Such grants are routine corporate compensation and do not, by themselves, indicate the director sold or bought shares in the open market.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-06-10+196,299→ 196,299 totalExercise: $1.15Exp: 2036-06-09→ Common Stock (196,299 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.